Neuromeka Co., Ltd. (KOSDAQ:348340)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,470
+1,070 (5.82%)
Sep 18, 2026, 3:30 PM KST

Neuromeka Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
18,15618,95425,26913,7439,7557,351
Other Revenue
0-----0
18,15618,95425,26913,7439,7557,351
Revenue Growth
-13.12%-24.99%83.87%40.89%32.69%80.81%
Cost of Revenue
14,82015,63421,20912,5808,6725,555
Gross Profit
3,3363,3204,0611,1631,0831,797
Selling, General & Admin
11,43310,75711,5978,2856,2112,935
Research & Development
5,8375,4246,6205,2641,923931.67
Amortization of Goodwill & Intangibles
121.2112.93118.84106.0488.8538.31
Other Operating Expenses
361.58502.96485.04253.64242.51123.31
Operating Expenses
19,59318,17723,49915,9898,8924,806
Operating Income
-16,257-14,857-19,439-14,825-7,809-3,009
Interest Expense
-3,861-5,290-4,929-2,050-292-532.95
Interest & Investment Income
450.15480.21626.11,097315.757.4
Earnings From Equity Investments
-363.12-424.4524.55-27.31--
Currency Exchange Gain (Loss)
15.16-18.1424.6699.8472.27115.2
Other Non Operating Income (Expenses)
-22,475-2,2476,472-2,150-487.07-3,201
EBT Excluding Unusual Items
-42,490-22,356-17,221-17,856-8,201-6,570
Gain (Loss) on Sale of Investments
--494.01282.13--
Gain (Loss) on Sale of Assets
1,677-124.522.36-72.2--23.88
Other Unusual Items
555.57555.57----
Pretax Income
-40,258-21,925-16,724-17,646-8,201-6,594
Income Tax Expense
66.3166.3130.577.1--
Earnings From Continuing Operations
-40,324-21,991-16,755-17,654-8,201-6,594
Minority Interest in Earnings
168.518.08----
Net Income
-40,156-21,973-16,755-17,654-8,201-6,594
Net Income to Common
-40,156-21,973-16,755-17,654-8,201-6,594
Net Income Growth
------
Shares Outstanding (Basic)
181716161311
Shares Outstanding (Diluted)
181716161311
Shares Change
9.16%6.52%1.17%21.12%19.56%440.13%
EPS (Basic)
-2264.87-1304.25-1059.33-1129.22-635.33-610.82
EPS (Diluted)
-2264.87-1304.25-1059.33-1129.33-635.33-610.82
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-23,819-14,511-35,625-42,925-11,008-1,267
Free Cash Flow Per Share
-1343.47-861.34-2252.43-2745.71-852.86-117.31
Gross Margin
18.38%17.52%16.07%8.46%11.10%24.44%
Operating Margin
-89.54%-78.38%-76.93%-107.88%-80.06%-40.93%
Profit Margin
-221.17%-115.93%-66.30%-128.46%-84.07%-89.70%
Free Cash Flow Margin
-131.19%-76.56%-140.98%-312.34%-112.85%-17.23%
EBITDA
-13,239-12,025-17,117-13,819-6,908-2,120
EBITDA Margin
-72.92%-63.44%-67.74%-100.55%-70.82%-28.84%
D&A For EBITDA
3,0182,8322,3221,007901.29888.92
EBIT
-16,257-14,857-19,439-14,825-7,809-3,009
EBIT Margin
-89.54%-78.38%-76.93%-107.88%-80.06%-40.93%
Advertising Expenses
-357.64764.89605.54145.2727.26